Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Cogent Biosciences (COGT) Shares Issued (2017 - 2021)

Cogent Biosciences has reported Shares Issued over the past 5 years, most recently at $7000.0 for Q4 2021.

  • Quarterly results put Shares Issued at $7000.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $20000.0 (down 58.33% YoY), and the annual figure for FY2025 was $11.5 million, up 5702.01%.
  • Shares Issued for Q4 2021 was $7000.0 at Cogent Biosciences, down from $13000.0 in the prior quarter.
  • Over the last five years, Shares Issued for COGT hit a ceiling of $61.8 million in Q3 2018 and a floor of -$66.2 million in Q4 2018.
  • Median Shares Issued over the past 5 years was $20500.0 (2018), compared with a mean of -$6.1 million.
  • Biggest five-year swings in Shares Issued: plummeted 147175.56% in 2018 and later surged 218.18% in 2020.
  • Cogent Biosciences' Shares Issued stood at $45000.0 in 2017, then plummeted by 147175.56% to -$66.2 million in 2018, then skyrocketed by 100.15% to $97000.0 in 2019, then tumbled by 86.6% to $13000.0 in 2020, then tumbled by 46.15% to $7000.0 in 2021.
  • The last three reported values for Shares Issued were $7000.0 (Q4 2021), $13000.0 (Q3 2020), and $35000.0 (Q1 2020) per Business Quant data.